Literature DB >> 23360832

Insulin resistance and glucose and lipid concentrations in a cohort of perinatally HIV-infected Latin American children.

Rohan Hazra1, Laura Freimanis Hance, Jacqueline Pontes Monteiro, Noris Pavia Ruz, Daisy Maria Machado, Mariza Saavedra, Fabrizio Motta, D Robert Harris.   

Abstract

We measured glucose, insulin and lipids in 249 perinatally HIV-infected Latin American children. Only 1 subject had impaired fasting glucose; 6.8% had insulin resistance. Abnormalities in total, low-density lipoprotein and high-density lipoprotein cholesterol and triglycerides were reported for 13%, 13%, 21% and 34%, respectively. Continued follow-up of this population is necessary to characterize the evolution and clinical consequences of these findings.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23360832      PMCID： PMC3695016          DOI： 10.1097/INF.0b013e318286c774

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  10 in total

1.  Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries.

Authors:  Rohan Hazra; Sonia K Stoszek; Laura Freimanis Hance; Jorge Pinto; Heloisa Marques; Mario Peixoto; Jorge Alarcon; Marisa Mussi-Pinhata; Leslie Serchuck
Journal:  Int J Epidemiol       Date:  2008-11-26       Impact factor: 7.196

2.  Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children.

Authors:  Marta Beregszaszi; Catherine Dollfus; Martine Levine; Albert Faye; Samia Deghmoun; Nassima Bellal; Muriel Houang; Didier Chevenne; Régis Hankard; Jean-Louis Bresson; Stéphane Blanche; Claire Levy-Marchal
Journal:  J Acquir Immune Defic Syndr       Date:  2005-10-01       Impact factor: 3.731

3.  Factors associated with insulin resistance among children and adolescents perinatally infected with HIV-1 in the pediatric HIV/AIDS cohort study.

Authors:  Mitchell E Geffner; Kunjal Patel; Tracie L Miller; Rohan Hazra; Margarita Silio; Russell B Van Dyke; William Borkowsky; Carol Worrell; Linda A DiMeglio; Denise L Jacobson
Journal:  Horm Res Paediatr       Date:  2011-10-26       Impact factor: 2.852

4.  Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood.

Authors:  David Dimock; Vijaya Thomas; Anna Cushing; Julia B Purdy; Carol Worrell; Jeffrey B Kopp; Rohan Hazra; Colleen Hadigan
Journal:  Metabolism       Date:  2010-10-13       Impact factor: 8.694

5.  Evaluation of insulin resistance in a cohort of HIV-infected youth.

Authors:  Raffaella Rosso; Arianna Parodi; Giuseppe d'Annunzio; Francesca Ginocchio; Laura Nicolini; Chiara Torrisi; Maria Pia Sormani; Renata Lorini; Claudio Viscoli; Marina Vignolo
Journal:  Eur J Endocrinol       Date:  2007-11       Impact factor: 6.664

Review 6.  Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection.

Authors:  Rohan Hazra; George K Siberry; Lynne M Mofenson
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

7.  Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.

Authors:  Grace M Aldrovandi; Jane C Lindsey; Denise L Jacobson; Amanda Zadzilka; Elizabeth Sheeran; Jack Moye; Peggy Borum; William A Meyer; Dana S Hardin; Kathleen Mulligan
Journal:  AIDS       Date:  2009-03-27       Impact factor: 4.177

8.  Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy.

Authors:  Caroline J Chantry; Michael D Hughes; Carmelita Alvero; Joseph S Cervia; William A Meyer; Janice Hodge; Peggy Borum; Jack Moye
Journal:  Pediatrics       Date:  2008-06-02       Impact factor: 7.124

9.  Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand.

Authors:  B Lee; L Aurpibul; V Sirisanthana; A Mangklabruks; T Sirisanthana; T Puthanakit
Journal:  HIV Med       Date:  2008-11-10       Impact factor: 3.180

10.  Lipodystrophy syndrome in human immunodeficiency virus-infected children.

Authors:  Rene A Amaya; Claudia A Kozinetz; Ann McMeans; Heidi Schwarzwald; Mark W Kline
Journal:  Pediatr Infect Dis J       Date:  2002-05       Impact factor: 2.129
  10 in total
  11 in total

Review 1.  Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update.

Authors:  Todd Hulgan
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

2.  Changes in insulin sensitivity over time and associated factors in HIV-infected adolescents.

Authors:  Mitchell E Geffner; Kunjal Patel; Denise L Jacobson; Julia Wu; Tracie L Miller; Rohan Hazra; Mariana Gerschenson; Tanvi Sharma; Margarita Silio; Jennifer Jao; Jody K Takemoto; Russell B Van Dyke; Linda A DiMeglio
Journal:  AIDS       Date:  2018-03-13       Impact factor: 4.177

3.  Insulin Resistance in South African Youth Living with Perinatally Acquired HIV Receiving Antiretroviral Therapy.

Authors:  Lisa J Frigati; Jennifer Jao; Sana Mahtab; Nana-Akua Asafu Agyei; Mark F Cotton; Landon Myer; Heather J Zar
Journal:  AIDS Res Hum Retroviruses       Date:  2018-09-25       Impact factor: 2.205

4.  Association of Dyslipidemia and Glucose Abnormalities With Antiretroviral Treatment in a Cohort of HIV-Infected Latin American Children.

Authors:  Machline P Paganella; Rachel A Cohen; Donald R Harris; Ricardo de Souza Kuchenbecker; Rosa D Sperhacke; Sergio K Kato; Carmem L Oliveira da Silva; Fernanda T Sturzbecher; Ricardo H S Oliveira; Noris Pavía-Ruz; Rohan Hazra
Journal:  J Acquir Immune Defic Syndr       Date:  2017-01-01       Impact factor: 3.731

5.  Getting to 90-90-90 in paediatric HIV: What is needed?

Authors:  Mary-Ann Davies; Jorge Pinto; Marlène Bras
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396

6.  Prevalence and predictors of bone health among perinatally HIV-infected adolescents.

Authors:  Sana Mahtab; Chris Scott; Nana Akua A Asafu-Agyei; Takwanisa Machemedze; Lisa Frigati; Landon Myer; Heather J Zar
Journal:  AIDS       Date:  2020-11-15       Impact factor: 4.632

7.  Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults.

Authors:  Daniel Blázquez; José Tomás Ramos-Amador; Talía Saínz; María José Mellado; Marta García-Ascaso; María Isabel De José; Pablo Rojo; María Luisa Navarro; María Ángeles Muñoz-Fernández; Jesús Saavedra; Miguel Angel Roa; Santiago Jiménez; José Beceiro; Luis Prieto; Milagros García Hortelano; María Isabel González-Tomé
Journal:  BMC Infect Dis       Date:  2015-03-08       Impact factor: 3.090

8.  Metabolic Disorders in HIV-Infected Adolescents Receiving Protease Inhibitors.

Authors:  Jeerunda Santiprabhob; Surapong Tanchaweng; Sirinoot Maturapat; Alan Maleesatharn; Watcharee Lermankul; Sirintip Sricharoenchai; Orasri Wittawatmongkol; Keswadee Lapphra; Wanatpreeya Phongsamart; Kulkanya Chokephaibulkit
Journal:  Biomed Res Int       Date:  2017-02-15       Impact factor: 3.411

Review 9.  The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents.

Authors:  Annette H Sohn; Rohan Hazra
Journal:  J Int AIDS Soc       Date:  2013-06-18       Impact factor: 5.396

10.  The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children.

Authors:  Rachel C Vreeman; Michael L Scanlon; Megan S McHenry; Winstone M Nyandiko
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.